OncoGenesis

Onco Genesis

Medical Devices, Salt Lake City, Utah, United States, 1-10 Employees

oncogenesisdx.com

  • LinkedIn

phone no Phone Number: +16*********

Who is ONCOGENESIS

OncoGenesis addresses the tremendous, unmet clinical need for an easy-to-use and accurate screening of women for cervical cancer. The company offers a comprehensive solution ranging from ...

Read More

map

industries-icon Industry: Medical Devices

SIC SIC Code: 3841 | NAICS Code: 339112 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from ONCOGENESIS

OncoGenesis Org Chart and Mapping

Teresa Prego

Chief Executive Officer

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding OncoGenesis

Answer: OncoGenesis's headquarters are located at Salt Lake City, Utah, United States

Answer: OncoGenesis's phone number is +16*********

Answer: OncoGenesis's official website is https://oncogenesisdx.com

Answer: OncoGenesis's revenue is $10 Million to $25 Million

Answer: OncoGenesis's SIC: 3841

Answer: OncoGenesis's NAICS: 339112

Answer: OncoGenesis has 1-10 employees

Answer: OncoGenesis is in Medical Devices

Answer: OncoGenesis contact info: Phone number: +16********* Website: https://oncogenesisdx.com

Answer: OncoGenesis addresses the tremendous, unmet clinical need for an easy-to-use and accurate screening of women for cervical cancer. The company offers a comprehensive solution ranging from optimal specimen collection to point-of-care diagnostic testing, setting a new standard of care for diagnosing and treating cervical cancer worldwide. Our goal is to provide a solution that clinically outperforms existing screening technologies in a cost-effective format that can be run anywhere globally, including resource-limited regions of the world where the problem of cervical cancer is a healthcare crisis. To accomplish this, OncoGenesis has developed a useful self-collection device, iPap, that allows women to obtain their cervical specimens in the privacy of their homes. The company is also developing the CerMark multiplex biomarker test that measures the critical cellular changes in a cervical tissue specimen to detect cervical cancer and its progression. The CerMark test will be available first on a laboratory-based system (LAB) and then on our Point-of-Care (POC) device.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access